Zobrazeno 1 - 6 of 6 pro vyhledávání: '"R. C. Sachdeo"'
1
Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy [RETIRED]
Autor: J. A. French, A. M. Kanner, J. Bautista, B. Abou-Khalil, T. Browne, C. L. Harden, W. H. Theodore, C. Bazil, J. Stern, S. C. Schachter, D. Bergen, D. Hirtz, G. D. Montouris, M. Nespeca, B. Gidal, W. J. Marks, W. R. Turk, J. H. Fischer, B. Bourgeois, A. Wilner, R. E. Faught, R. C. Sachdeo, A. Beydoun, T. A. Glauser
Publikováno v: Neurology. 62:1261-1273
Objective: To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) (gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, and zonisamide) in the treatment of children and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9819cf6191510d9f22a3970ba5ecf99e
https://doi.org/10.1212/01.wnl.0000123695.22623.32
Zobrazit plný text záznamu
2
Long-Term Experience with Topiramate as Adjunctive Therapy and as Monotherapy in Patients with Partial Onset Seizures: Retrospective Survey of Open-Label Treatment
Autor: William E. Rosenfeld, Michael Privitera, R E. Faught, R. C. Sachdeo
Publikováno v: Epilepsia. 38:S34-S36
Because initial studies of new antiepileptic drugs (AEDs) are add-on trials in refractory patient populations, their effectiveness as monotherapy is usually not apparent until relatively later in their development programs. The novel AED topiramate (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999dc696ba655d0c827fbcf612d78dc4
https://doi.org/10.1111/j.1528-1157.1997.tb04516.x
Zobrazit plný text záznamu
3
Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group
Autor: T A, Glauser, P M, Levisohn, F, Ritter, R C, Sachdeo
Publikováno v: Epilepsia. 41(S1)
The response to topiramate (TPM) as long-term adjunctive therapy was evaluated in patients with Lennox-Gastaut syndrome (LGS) in a long-term, open-label extension to a double-blind, placebo-controlled trial.In 97 patients with LGS (mean age, 11 years
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c37295962d064f28d1bb3bd9f2eca444
https://pubmed.ncbi.nlm.nih.gov/10768308
Zobrazit plný text záznamu
4
A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group
Autor: R C, Sachdeo, T A, Glauser, F, Ritter, R, Reife, P, Lim, G, Pledger
Publikováno v: Neurology. 52(9)
To evaluate the efficacy and safety of topiramate as adjunctive therapy for Lennox-Gastaut syndrome in a multicenter, double-blind, placebo-controlled trial.Conventional antiepileptic drugs are frequently ineffective against multiple-seizure types of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3fae4a37524b94ca1653ccece02bcbbb
https://pubmed.ncbi.nlm.nih.gov/10371538
Zobrazit plný text záznamu
5
Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group
Autor: R C, Sachdeo, R F, Leroy, G L, Krauss, M E, Drake, P M, Green, I E, Leppik, V S, Shu, G L, Ringham, K W, Sommerville
Publikováno v: Archives of neurology. 54(5)
To evaluate the efficacy and safety of 2 regimens of tiagabine as add-on therapy for patients with complex partial seizures (CPSs) that are refractory to other treatment.Randomized, double-blind, placebo-controlled, add-on, parallel-group trial with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::eaf77589602681d907a7fcfad1c7b9ee
https://pubmed.ncbi.nlm.nih.gov/9152116
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje